Literature DB >> 321174

The central hypotensive effect of clonidine. Studies in tetraplegic subjects.

J L Reid, L M Wing, C J Mathias, H L Frankel, E Neill.   

Abstract

A single oral dose of 300 microng of clonidine lowered systolic blood pressure by 20 +/- 4 mm Hg and diastolic blood pressure by 13 +/- 4 mm Hg in five healthy normotensive subjects (controls). Heart rate fell from 56 +/- 2 to 52 +/- 2 beats/min. In six tetraplegic subjects with physiologically complete chronic cervical spinal cord transection above the level of the sympathetic outflow, the same dose of clonidine did not significantly lower either systolic or diastolic blood pressure. Heart rate fell from 67 +/- 4 to 53 +/- 2 beats/min. Peak plasma concentrations of clonidine, measured by mass fragmentography, and elimination of the drug from plasma were similar in tetraplegic and control subjects and there was no difference in the incidence of the principal side effects of clonidine--sedation and dry mouth. Although the number of subjects studied is small, the absence of a fall in blood pressure after clonidine in the tetraplegic subjects suggests that the hypotensive action of clonidine in man is dependent on intact descending bulbospinal pathways and is mediated by withdrawal of sympathetic tone and provides direct evidence that some antihypertensive drugs may lower blood pressure in man by a direct action on the brain.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 321174     DOI: 10.1002/cpt1977214375

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  19 in total

1.  The use of clonidine in the management of autonomic overactivity in neuroleptic malignant syndrome.

Authors:  L Gregorakos; T Thomaides; S Stratouli; E Sakayanni
Journal:  Clin Auton Res       Date:  2000-08       Impact factor: 4.435

Review 2.  [Strategies for perioperative sympatho-modulation].

Authors:  J Wacker; T Pasch; M C Schaub; M Zaugg
Journal:  Anaesthesist       Date:  2005-04       Impact factor: 1.041

3.  A comparison of the haemodynamic and behavioural effects of moxonidine and clonidine in normotensive subjects.

Authors:  G J Macphee; C A Howie; H L Elliott; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1992-03       Impact factor: 4.335

Review 4.  Drugs interacting with alpha adrenoceptors.

Authors:  P A van Zwieten
Journal:  Cardiovasc Drugs Ther       Date:  1989-04       Impact factor: 3.727

Review 5.  Neurogenic aspects of essential hypertension in man.

Authors:  G A FitzGerald
Journal:  Ir J Med Sci       Date:  1979-12       Impact factor: 1.568

Review 6.  Central nervous system mechanisms in blood pressure control.

Authors:  A D Struthers; C T Dollery
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

7.  Studies on the autonomic nervous system in borderline hypertension.

Authors:  J W Henquet; M van Baak; M Schols; K H Rahn
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

Review 8.  Antihypertensive pharmacology.

Authors:  J G Gerber; C R Freed; A S Nies
Journal:  West J Med       Date:  1980-05

9.  Differences in psychic performance with guanfacine and clonidine in normotensive subjects.

Authors:  J Kugler; R Seus; R Krauskopf; H M Brecht; A Raschig
Journal:  Br J Clin Pharmacol       Date:  1980       Impact factor: 4.335

10.  Pharmacokinetic and concentration-effect relationships of clonidine in essential hypertension.

Authors:  L M Wing; J L Reid; D S Davies; E A Neill; P Tippett; C T Dollery
Journal:  Eur J Clin Pharmacol       Date:  1977-12-28       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.